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A B S T R A C T
The aim of the study was to determine the prevalence of vaginal group B streptococcus (GBS) colonization in pregnant
women from Osijek area, the possible effect of GBS colonization on pregnancy outcome and neonatal complications and
the role of intrapartum prophylaxis in this context. This retrospective case-control study took place at the Department of
Gynecology and Obstetrics, Osijek University Hospital Center from December 2003 to June 2006. A total of 118 pregnant
women was enrolled in study and divided into two groups: 59 women in 35th–37th week of gestation, free from risk factors
for infection (control group); and 59 women in 25th–41st week of gestation with risk factors for infection. Low vaginal
swab for GBS isolation and identification on selective and enriched medium was obtained from each woman. GBS colo-
nization was recorded in 29 (24.6%) women: 12 (20.3%) control and 17 (28.8%) women at risk of infection, yielding a sta-
tistically non-significant difference (c2=1.480489; p<0.48). Early neonatal infection was observed in six (20.7%) neo-
nates born to 29 mothers with GBS colonization, pointing to a correlation between vaginal GBS colonization and early
neonatal infection (rs=0.99). Early perinatal infection was found in 22 (18.6%) neonates, including 17 (28.8%) pregnan-
cies with risk factors, pointing to a significant correlation between vaginal GBS colonization, risk factors and early
perinatal infection (c2=88.68; p<0.001); however, gestational age and pregnancy outcome were not influenced by GBS
colonization. In eight (36.4%) newborns, early neonatal infection developed in spite of intrapartum administration of an-
tibiotics; three of these children were born to GBS positive mothers, and perinatal GBS infection was demonstrated in
one (0.84%) child. Study results revealed a relatively high rate of GBS colonization in the population of pregnant women
in Croatia, occasionally leading to early neonatal infection. Large studies are needed to develop national strategy for the
prevention of GBS infection in Croatia.
Key words: group B streptococcus (GBS), pregnancy, neonatal infection, early neonatal group B streptococcal septice-
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Introduction
The prevalence of genital system colonization with
beta-hemolytic serogroup B streptococcus (group B strep-
tococcus, GBS) is estimated to 5–40% of healthy women,
varying among different populations. Vaginal or rectal
GBS colonization, found in 10–30% of pregnant women1,
can cause puerperal sepsis, vaginitis, urinary infections
in otherwise normal individuals, skin infections and en-
docarditis2.
In the 1990s, guidelines for the prevention of neo-
natal GBS infection were developed in most western
European countries and the USA, which have resulted
in a significant reduction in the incidence of these in-
fections in these countries. In spite of this favorable
tendency, GBS remains the major cause of neonatal
morbidity and mortality of infectious etiology in the
western world2,3.
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In newborns, the disease develops as early-onset neo-
natal infection within the first 7 days of birth or as the
late-onset form that develops at 7 or more days of birth.
Neonatal infection manifests with sepsis, pneumonia
and meningitis, however, soft tissue and bone infection
may also occur1,4,5. The mean rate of GBS transmission
to newborns is 60% (40–70%). Early-onset neonatal in-
fection is recorded in 1–3% of children born to mothers
with GBS colonization1. The newborn’s passage through
the infected birth canal may result in GBS induced early
neonatal septicemia, with a mortality rate of 20–30%6.
Early-onset neonatal disease caused by GBS accounts for
80% of all GBS infections in childhood and is associated
with severe neurologic sequels in 5% of cases7.
Late-onset neonatal disease results from horizontal
transmission, with a prevalence of 1.3–1.6/1000 new-
borns1. The pathogenesis of this form of GBS caused dis-
ease is less known. In some cases, it develops upon micro-
organism acquisition during the newborn’s passage through
the birth canal1.
The risk factors that can lead to the development of early
neonatal group B streptococcal septicemia (ENGBSS)
are well defined. Besides maternal vaginal swab positive
for GBS, the following factors can result in an increased
incidence of early-onset neonatal infection: amniotic sac
rupture for more than 18 hours, premature delivery
(<37 weeks), amniotic sac rupture before 37th week of
gestation, body temperature at delivery of 38 C or more,
GBS in urine during pregnancy, and neonate born with
ENGBSS8,9. Although vaccination of pregnant women
that would also protect the newborns has been investi-
gated1,10, chemoprophylaxis is the only preventive mea-
sure currently available. The wide use of intrapartum
antibiotic chemoprophylaxis has reduced the incidence of
early-onset neonatal disease but has limited effects due
to inadequate routine use of rapid tests (such as polymer-
ase chain reaction, PCR). Thus, intrapartum antibiotic
prophylaxis is generally administered ex iuvantibus, in
premature and precipitate deliveries in particular. Such
prophylaxis may prove inefficient and inappropriate ac-
cording to choice and dosage, and may lead to the devel-
opment of antibiotic resistance, hypersensitivity reac-
tions, GBS substitution by other infective agents, gram-
-negative bacteria in particular, and inefficiency of pre-
ventive measures for the late-onset neonatal GBS in-
fection7,8.
The protocols for prevention of GBS infection have
not yet been adopted in many countries, including Croa-
tia. Two alternative approaches in the preventive strat-
egy are available to obstetricians, i.e. the approach based
on screening and another one based on risk factors. The
former is based on the screening of all pregnant women
at 35th–37th week of gestation to detect anogenital GBS
colonization. All pregnant women identified as GBS car-
riers (even without the presence of risk factors) should
receive antibiotic therapy (chemoprophylaxis) by venous
route until delivery1,11,12. The alternative approach is
based on risk factors and antibiotics are administered
intrapartum to pregnant women where delivery occurs
before 37th week of gestation, amniotic sac rupture for
more than 18 hours, body temperature higher than 38
C, a history of a newborn with GBS infection, and in
women with GBS bacteriuria detected during pregnancy.
Chemoprophylaxis is administered to pregnant women
with risk factors recorded on admission to the hospital,
irrespective of GBS identification1,13–15.
The aim of the present study, the first of this kind in
Croatia, was to determine the prevalence of vaginal GBS
colonization in the population of pregnant women in the
Osijek area; to determine the prevalence of early-onset
neonatal infection and its association with maternal GBS
colonization and intrapartum prophylaxis; to determine
whether GBS colonization is more likely in women with
risk pregnancy and whether maternal GBS colonization
is an additional risk factor for premature delivery, un-
timely amniotic sac rupture, positive urinary culture and
development of early-onset neonatal infection of the new-
born; and to determine correlation of GBS positive uri-
nary culture and vaginal GBS colonization.
Materials and Methods
The study included 118 pregnant women from the
Osijek area, east Croatia, followed-up at the Department
of Gynecology and Obstetrics, Osijek University Hospital
Center, between December 2003 and June 2006. Study
women were divided into two groups: control group con-
sisting of 59 pregnant women at 35th to 37th week of ges-
tation, free from risk factors for GBS infection, examined
and followed-up at Outpatient Obstetric Clinic, Depart-
ment of Gynecology and Obstetrics, Osijek University
Hospital Center; vaginal swab was obtained on routine
follow-up examination; and study group consisting of 59
pregnant women at 25th to 41st week of gestation, with
risk factors for GBS infection (premature delivery, un-
timely amniotic sac rupture, body temperature >38 C,
signs of intra-amniotic infection, urinary culture positive
for GBS, hospitalized at Division of Pregnancy Pathol-
ogy, Department of Gynecology and Obstetrics, Osijek
University Hospital Center; vaginal swab was obtained
on hospital admission.
The two groups of pregnant women were analyzed ac-
cording to age, number of deliveries, level of education,
marital status, gestational age, newborn sex, type of de-
livery, number of fetal/neonatal deaths, birth weight,
Apgar score, and early neonatal period of their infants.
The prevalence of vaginal GBS colonization was deter-
mined in both study groups. The early neonatal period
was monitored and newborns with clinical signs of peri-
natal infection were analyzed. The diagnosis of perinatal
infection was based on clinical picture, laboratory test
findings and microbiology of blood culture, urinary cul-
ture, gastric aspirate and tip of tubus. In neonates with
perinatal infection, comparison with the maternal gesta-
tional vaginal swab microbiology findings, GBS positive
in particular, and with/without intrapartum antibiotic
prophylaxis was performed.
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Urinary culture was done in all women exhibiting
signs of urinary tract infection. The sample for vaginal
colonization testing was obtained without the use of
speculum, i.e. the swab was obtained through introitus
by wiping the inferior vaginal wall and anus11,12. Isola-
tion and identification of the grown bacteria were per-
formed at laboratory of microbiology, according to Cen-
ters for Disease Control and Prevention (CDC) recom-
mendations11,12. All samples were incubated in aerobic
conditions at a temperature of 37C in selective and en-
riched Todd-Hewitt buillon with the addition of gen-
tamicin (8 mg/L) and nalidixic acid (15 mg/L). Then,
sample subcultivation on solid nutritive medium (strep-
tococcus selective agar, Biolife, Italy: Todd-Hewitt broth,
Biolife, Italy) was performed. Gram-positive catalase-
-negative cocci with a narrow b hemolysis zone were
tested by the method of latex agglutination, a standard
microbiology method for identification of group B strep-
tococci (Prolex TM, latex agglutination system, Strepto-
coccal Grouping Latex kit for identification of groups A,
B, C, D, F or G streptococci; Pro-lab Diagnostics, Can-
ada).
Prior to enrolment in the study, each woman was
thoroughly informed on the objectives and purpose of the
study, and gave her informed consent for inclusion. The
study was approved by the Osijek School of Medicine
Ethics Committee, and all procedures used in the study
were performed in line with ethical standards, recom-
mendations of the Osijek School of Medicine Ethics Com-
mittee and Helsinki Declaration provisions.
Statistical analysis of the data obtained was per-
formed by use of the specialized Statistica 6.0, StatSoft
Inc. software, processed by the methods of descriptive
statistics and compared by use of c2-test and Spearman
correlation coefficient.
Results
The group of pregnant women free from risk factors
after 35th week of gestation (control group) and the group
of women with the presence of risk factors (premature
delivery with or without untimely amniotic sac rupture,
premature amniotic sac rupture for >18 hours, elevated
body temperature, signs of intra-amniotic infection, posi-
tive urinary culture, and delivery of a newborn with
ENGBSS in history) were statistically significantly com-
parable according to all epidemiological variables (age,
sequence of deliveries, level of education, marital status,
type of delivery, and newborn age and Apgar score).
Analysis according to gestational age revealed a high
statistically significant between-group difference in ges-
tational age and newborn birth weight. The rate of pre-
mature delivery (below 37th week of gestation) was 5.1%
in the control group versus 61.0% in the group at risk
(c2=30.26; p<0.001). The newborn birth weight of 2500
g was recorded in 5.1% and 42.4% of control group and
risk group women, respectively (c2=19.37; p<0.001).
Microbiology of low vaginal swab revealed GBS colo-
nization in a total of 29 (24.6%) women, including 12
(20.3%) control group women and 17 (28.8%) risk group
women (c2=1.48; p<0.48), yielding no statistically signif-
icant between-group difference (Table 1).
Early neonatal period in children born to mothers
with GBS colonization is illustrated in Table 2. Signs of
early-onset neonatal infection were observed in six (20.7%)
children of 29 GBS colonized mothers. Spearman corre-
lation coefficient (rs=0.99) indicated very high mathe-
matical correlation between vaginal GBS colonization
and early neonatal infection irrespective of the causative
agent identified.
Clinical and laboratory signs of early-onset perinatal
infection were found in 22 (18.6%) newborns (Table 1),
i.e. five (8.5%) newborns from the control group and 17
(28.8%) newborns from the risk group (c2=88.68; p<
0.001). These results pointed to a high, statistically sig-
nificant between-group difference in the presence of risk
factors, while at the same time suggesting the presence
of risk factors to be independent of vaginal colonization.
This in turn implied that bacterial colonization had no
effect on gestational age and pregnancy outcome.
Eight (36.4%) of 22 newborns with the signs of early-
-onset neonatal infection including four children born to
GBS positive mothers had received intrapartum antibi-
otic prophylaxis. The causative agent was isolated in
three (75.0%) and GBS infection was demonstrated in
one (0.84%) of these four newborns (Table 3).
Positive urinary culture was found in 26 (50.0%) of 52
women exhibiting symptoms of urinary tract infection
(Table 4). GBS was isolated in 12 (23.1%) women and
was by far the most common causative agent. The corre-
lation of GBS positive urinary culture and vaginal GBS
colonization is shown in Table 5. Vaginal GBS coloniza-
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TABLE 1
PREVALENCE OF VAGINAL GROUP B STREPTOCOCCUS (GBS)
COLONIZATION IN PREGNANT WOMEN FROM OSIJEK AREA
ACCORDING TO STUDY GROUPS
Vaginal GBS
colonization
Control group (%) Risk group (%) Total (%)
(+) positive 12 (20.3) 17 (28.8) 29 (24.6)
(–) negative 47 (79.7) 42 (71.2) 89 (75.4)
Total 59 (100.0) 59 (100.0) 118 (100.0)
TABLE 2
EARLY NEONATAL PERIOD IN NEWBORNS TO MOTHERS WITH
GROUP B STREPTOCOCCUS (GBS) COLONIZATION FROM







Infection 1 (8.3) 5 (29.4) 6 (20.7)
Asphyxia 0 (0.0) 1 (5.9) 1 (3.5)
Intracranial hemorrhage 0 (0.0) 1 (5.9) 1 (3.5)
Normal finding 11 (91.7) 10 (58.8) 21 (72.3)
Total 12 (100.0) 17 (100.0) 29 (100.0)
tion was present in 12 women with GBS positive urinary
culture, pointing to their high correlation (rs=0.99) whe-
reby the likelihood of vaginal colonization considerably
increased with positive urinary culture.
Discussion and Conclusion
Although being normal commensal and part of the
complex microflora of the gastrointestinal and genitouri-
nary tract, Streptococcus agalactiae (GBS) is a major
cause of severe neonatal infections1,4–7,16. Some 10% to
35% of pregnant and non-pregnant women are (mostly
asymptomatic) GBS carriers8,17. The increasing utilization
of antibiotics as the only prophylaxis currently available,
especially in cases of penicillin hypersensitivity, is a mat-
ter of growing concern about the increasing bacterial re-
sistance, thus questioning the efficacy of intrapartum
prophylaxis17. In addition, it remains obscure why GBS
causes colonization in some pregnant women and leads
to infection in others; colonization density, virulence
variability among GBS clones and infection sensitivity of
the host play a role in the development of infection17,18.
In Croatia, there are no data or systematic monitor-
ing of the prevalence of neonatal disease irrespective of
the causative agent, including the prevalence of neonatal
infection caused by GBS. There is no consensus on the
monitoring of pregnant and non-pregnant women with
GBS colonization either.
On comparison of the group of pregnant women with
risk factors with control group, the rate of women with
GBS colonization was not statistically significantly hi-
gher in the former. However, the risk of early-onset neo-
natal infection was statistically significantly increased by
the presence of GBS colonization in the group of women
with risk factors, but had no impact on the term (pres-
ence of risk factors in the antenatal period) and outcome
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TABLE 3
EARLY PERINATAL INFECTION IN NEWBORNS TO MOTHERS FROM OSIJEK AREA ACCORDING TO THE USE OF INTRAPARTUM
PROPHYLAXIS
Microbiology (isolate)
Control group n=5 (8.5%) Risk group n=17 (28.8%) Total n=22 (18.6%)
Intrapartum prophylaxis Intrapartum prophylaxis Intrapartum prophylaxis
Yes No Yes No Yes No
Total 2 3 6 11 8 14
Blood culture and urinary culture sterile 1 0 4 (1*) 6 (1*) 5 (1*) 6 (1*)
Gastric aspirate Escherichia coli 0 0 0 1 0 1
Gastric aspirate Klebsiella 0 0 0 1 0 1
MRSE tip of tubus 0 2 0 2 0 4
Blood culture Staphylococcus epidermidis 0 1 1* 0 11 1
Urinary culture Klebsiella 1* 0 0 1* 1* 1*
Blood culture GBS 0 0 1* 0 1* 0
*GBS (+) positive mother; GBS – group B streptococcus
TABLE 4
ANALYSIS OF URINARY CULTURE IN PREGNANT WOMEN FROM OSIJEK AREA TESTED FOR GROUP B STREPTOCOCCUS (GBS)
COLONIZATION
Microbiology (isolate) Control group n=29 (49.2 %) Risk group n=23 (39.0%) Total n=52 (44.1%)
GBS 2 (6.9) 10 (43.5) 12 (23.1)
Escherichia coli 6 (20.7) 1 (4.3) 7 (13.5)
Enterococcus faecalis 2 (6.9) 2 (8.7) 4 (7.7)
Proteus mirabilis 1 (3.5) 0 (0.0) 1 (1.9)
Staphylococcus aureus 1 (3.5) 0 (0.0) 1 (1.9)
Staphylococcus epidermidis 0 (0.0) 1 (4.3) 1 (1.9)
Sterile finding 17 (58.6) 9 (39.1) 26 (50.0)
TABLE 5
CORRELATION OF GROUP B STREPTOCOCCUS (GBS) POSITIVE
(+) URINARY CULTURE AND GBS POSITIVE (+) VAGINAL SWAB
IN PREGNANT WOMEN FROM OSIJEK AREA









Total 2 (3.4) 10 (16.9) 12 (10.2)
GBS 1 (50.0) 6 (60.0) 7 (58.3)
Other bacteria 1 (50.0) 4 (40.0) 5 (41.7)
of delivery. Our study results suggested that vaginal GBS
colonization significantly increased the likelihood of ear-
ly neonatal disease in the newborn irrespective of the
causative agent, since more than 20% of children born to
mothers with GBS colonization developed this neonatal
disease.
Furthermore, the use of intrapartum antibiotic pro-
phylaxis (in women with or without bacterial coloniza-
tion) was found to fail to prevent the onset of early neo-
natal disease with certainty, since over one-third (36.4%)
of children developed the disease in spite of prophylaxis.
Despite prophylaxis, at least one causative agent, includ-
ing GBS in one child, was demonstrated in three of four
(75.0%) children born to GBS positive mothers. These
findings have opened an array of other issues in the field.
Namely, due to the lack of rapid tests such as PCR, in-
cluding antibiotic sensitivity of the causative agents, in
daily routine, intrapartum antibiotic prophylaxis is gen-
erally administered on the basis of individual assessment
and experience, ex iuvantibus. In our study, results of
swab testing were not known during labor, in the group
at risk in particular, because rapid tests were not avail-
able and intrapartum prophylaxis was not used, not even
in women with verified bacterial colonization. On the
other hand, the prophylaxis administered without the
antibiotic sensitivity report (of GBS and other agents)
was, conceivably, only partially efficient. In addition, the
possible development of resistance, hypersensitivity re-
action to antibiotic therapy and GBS substitution by an-
other causative agent(s), gram-negative in particular,
should always be considered.
Correlation was also found between GBS positive uri-
nary culture and vaginal GBS colonization, whereby the
former increased the likelihood of the latter; accordingly,
GBS positive urinary culture should be considered as an
indication for prompt therapy introduction, as suggested
by most literature reports19. A meta-analysis of the prev-
alence of vaginal GBS colonization in 24,093 women
from 13 European countries, reported in 2008, found it
to range from 6.5 to 36.0%, but exceeding 20.0% in
one-third of the studies included3. The same report de-
scribes regional variations in the prevalence of vaginal
GBS colonization among particular regions of Europe,
i.e. 19.7–29.3% in eastern Europe, 11.0–21.0% in western
Europe, 24.3–36.0% in northern Europe, Scandinavia in
particular, and 6.5–32.0% in southern Europe3. Data ob-
tained in our study on vaginal GBS colonization recorded
in 24.6% of study women are comparable with these data,
yet indicating the rate of GBS colonization in Croatian
women to exceed the rate recorded in western European
countries.
Our study as the first of the kind in Croatia suffered
from some limitations. Verified additional and independ-
ent risk factors such as diabetes20, increased body mass
index21, intensity of sexual activities and number of
partners22,23, increased number of examinations and of
intravaginal and intrauterine manipulations in general24
were not taken in consideration and should be involved
in future studies.
CDC has issued recommendations for the prophylaxis
of GBS infection11,12,25. Based on these recommendations
and epidemiological studies, national strategies for the
prevention of GBS infections, aimed at identification of
pregnant women at a high risk of neonatal GBS infection
in their newborns, have been developed in a number of
countries, e.g., Canada, UK, Ireland, Australia, etc.23,26,27.
In Croatia, data on the prevalence of GBS colonization
and early neonatal infection, GBS induced in particular,
should first be collected at the national and regional level
to start considering development of the procedure algo-
rithm for GBS colonization. This would certainly require
large-scale and comprehensive studies. In addition, in
the era characterized by the need of the most cost-effec-
tive and at the same time highly efficient and efficacious
health care, the question arises whether it is reasonable
to perform any preventive actions if the incidence of
ENGBSS is lower than 0.6 per 1000 live births9,11,12.
Anyhow, respective studies should be continued and
extended in Croatia. The announced introduction of a
GBS vaccine to be administered to pregnant women1,10
while also protecting the newborns is perceived as a de-
finitive solution, although the issues of indications, route
and timing of administration remain open. Maternal im-
munization against GBS appears to settle at long term
the problem of prevention of neonatal sepsis, premature
delivery and growth retardation in children28,29. GBS
type Ia, Ib and III capsular polysaccharides appear to be
efficient in the induction of type-specific antibodies in
healthy vaccinated pregnant women28. Antibodies to GBS
surface protein also contribute to the protection from
neonatal infection30. The GBS type Ia, II, III and V vac-
cine is expected to provide protection from more than
90% of infections, suggesting that the program of GBS
vaccination should take in consideration geographical
variations as well as monitoring of the prevalence GBS
serotypes as major guidelines to identify the components
of a polyvalent GBS vaccine7. Along with the develop-
ment of polyvalent GBS vaccine, the question arises of
vaccination timing, since vaccination in pregnancy is cer-
tainly controversial. Therefore, vaccination could poten-
tially be performed in women of reproductive age before
pregnancy, could be offered to adolescents, or even in-
cluded in regular pediatric immunization28.
In conclusion, GBS colonization of pregnant women
in Croatia is a complex problem because of its potential
severe sequels for both the mother and the child on the
one hand, and for the need of savings in health care in
general while ensuring the most efficient health care for
this vulnerable population group on the other hand.
Therefore, it is necessary for both clinicians and public
health professionals to be involved in solving the issue
because definitive conclusions on the development of the
national program of prevention of GBS infections and on
the type of health care measures to be included in such a
program under current conditions can only be made upon
large-scale and comprehensive epidemiological studies.
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U^ESTALOST I ZNA^AJ KOLONIZACIJE RODNICE STREPTOKOKOM GRUPE B TRUDNICA S
PODRU^JA GRADA OSIJEKA, HRVATSKA
S A @ E T A K
Cilj istra`ivanja bio je utvrditi u~estalost kolonizacije rodnice streptokokom grupe B (GBS) trudnica grada Osijeka.
Istra`iti ima li utvr|ena kolonizacija i kakav utjecaj na ishod trudno}e te na nastanak komplikacija kod ro|ene djece, te
kakva je kod toga uloga i zna~aj intrapartalne profilakse. Me|u trudnicama s podru~ja grada Osijeka pra}enim na
Odjelu za ginekologiju i opstetriciju Klini~kog bolni~kog centra Osijek, u razdoblju od prosinca 2003. godine do lipnja
2006. godine, provedeno je popre~no-presje~no istra`ivanje. Obra|eno je 118 trudnica podijeljenih u dvije skupine. U
probirnoj (kontrolnoj) skupini bilo je 59 trudnica u dobi od 35 do 37 tjedana trudno}e, bez rizi~nih ~imbenika za in-
fekciju, a u drugoj 59 trudnica s rizi~nim ~imbenicima za infekciju, trajanja trudno}e od 25 do 41 tjedna. Svakoj trudnici
uzet je donji vaginalni obrisak radi izolacije i identifikacije GBS na selektivnoj i oboga}enoj podlozi. Kolonizacija GBS-
-om utvr|ena je kod 29 (24.6%) `ena. U probirnoj skupini kod 12 (20.3%), a u rizi~noj skupini 17 (28.8%), bez statisti~ki
uo~ene razlike (c2=1.480489, p<0.48). Kod 6 (20.7%) novoro|en~adi od 29 koloniziranih `ena GBS-om utvr|ena je
rana neonatalna infekcija, {to govori o korelaciji kolonizacije rodnice GBS-om i rane neonatalne infekcije (rs=0.99).
Rana perinatalna infekcija javila se je kod 22 (18.6%) novoro|en~adi, pri ~emu 17 (28.8%) iz trudno}a `ena s rizi~nim
faktorima, {to ukazuje da postoji zna~ajna povezanost kolonizacije rodnice GBS-om, rizi~nih faktora i rane infekcije
djeteta (c2=88.68, p<0.001), no kolonizacija ne utje~e na trajanje i ishod trudno}e. Kod 8 (36.4%) djece se je rana
neonatalna infekcija javila usprkos intrapartalnoj primjeni antibiotika, 3 od njih bila su djeca GBS pozitivnih majki, a
kod jednog (0.84%) od njih dokazana je perinatalna infekcija GBS-om. Istra`ivanje je pokazalo kako je i u Hrvatskoj
kolonizacija GBS-om zna~ajna pojava u populaciji trudnica, koja u odre|enog broja trudnica mo`e rezultirati razvojem
rane neonatalne infekcije u njihove novoro|en~adi. Nu`no je provesti {ira i sveobuhvatnija istra`ivanja temeljem kojih
}e se donijeti nacionalna strategija za prevenciju neonatalnih GBS infekcija u Hrvatskoj.
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